Comparing risperidone and cariprazine for bipolar mania
Treatments studied
Part of Mental health clinical trials.
This trial compares two medicines, risperidone and cariprazine, to see which works better for treating acute mania in bipolar disorder. It aims to find a more effective option to help calm severe mood episodes quickly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old.
- You have bipolar disorder and are currently experiencing a manic episode.
- Your mania symptoms must be severe, scoring over 20 on a standard mania rating scale (YMRS).
- You cannot have a substance use problem (like drug or alcohol addiction).
- You should not be taking other antipsychotic medications right now.
- Your mood symptoms must be due to bipolar disorder, not another medical condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether clozapine works better for people whose illness fits a specific “biotype-1” pattern. It may help reduce ongoing symptoms, but it also requires close safety monitoring.
This study compares two medications, Lumateperone and Cariprazine, to see which works better and has fewer side effects for people with bipolar I depression. It may help find a more effective treatment for your depressive symptoms.
This trial compares lithium versus cariprazine to treat an episode of depression in people with bipolar disorder. It may help find which medicine works better and is safer during the acute (active) phase of depression.
This study compares two medications, carliprazine and aripiprazole, to see which works better for people having an acute (sudden worsening) episode of schizophrenia. If you qualify, you will receive one of these pills for several weeks, and the doctors will check your symptoms closely to see how you respond.
This Phase 3 study tests whether cariprazine can improve depression symptoms in children and teens with bipolar I disorder, and also tracks side effects. It may help if your depressive episode is ongoing and you meet specific mood and screening score requirements.
This Phase 4 trial tests how well cariprazine works by itself to reduce symptoms of major depressive disorder (MDD). You may be eligible if you’re currently in a depressive episode and your depression score stays within a certain range at both screening and study start.
Hear when a new Bipolar 1 Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.